HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Contraceptive Implant Hails New Era of Birth Control

By HospiMedica International staff writers
Posted on 22 Jul 2014
Print article
Image: A prototype contraceptive implant (Photo courtesy of MicroCHIPS).
Image: A prototype contraceptive implant (Photo courtesy of MicroCHIPS).
A fingernail-sized implant holds enough 30-microgram daily doses of levonorgestrel to provide contraception for 16 years.

Developed by MicroCHIPS (Lexington, MA, USA), a MIT (Cambridge, MA, USA) startup, the device, which measures just 20 x 20 x 7 millimeters, is designed to be implanted under the skin of the buttocks, upper arm, or abdomen. It then dispenses a daily dose levonorgestrel from a reservoir sealed with a titanium and platinum hermetic stopper. Passing an electric current through the stopper melts it temporarily, allowing a 30-microgram dose of the hormone to diffuse out each day.

Women who receive the implant also get a remote control that allows them to halt or restart the implant on demand; to conceive, women turn off the implant with a remote control; another click of the remote restarts it. Doctors could also adjust dosages remotely. MicroCHIPS have previously demonstrated how the microchip technology could release daily doses of an osteoporosis drug. The new application could revolutionize the level of control women have over their birth control technologies.

The technology also includes a secure encryption protocol to prevent outsiders from blocking or reprogramming the implants wirelessly. Another safety factor is that the device is triggered remotely by radio communication over a special frequency called Medical Implant Communication Service (MICS), which only works over a very short distance, almost requiring skin contact to function. The device will begin preclinical testing in the US in 2015, with the goal of market approval by 2018. The study describing the technology was published on July 4, 2014, in MIT Technology Review.

“The idea of using a thin membrane like an electric fuse was the most challenging and the most creative problem we had to solve,” said Robert Farra, president of MicroCHIPS. “We have heard a lot of positive feedback. Women are excited about the capability to change the state of an implant without having to go through another procedure to have it removed. They like the long-term medication, and not having to remember to take medication each day.”

Related Links:
MicroCHIPS
MIT


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Transportation Stretcher
ES709
New
Mobile Cart
MS550

Print article

Channels

Critical Care

view channel
Image: The Atmo Gas Capsule measures gases as it travels through the GI tract and transmits the data wirelessly (Photo courtesy of Atmo Biosciences)

Ingestible Smart Capsule for Chemical Sensing in the Gut Moves Closer to Market

Intestinal gases are associated with several health conditions, including colon cancer, irritable bowel syndrome, and inflammatory bowel disease, and they have the potential to serve as crucial biomarkers... Read more

Surgical Techniques

view channel
Image: The Elana Heart Bypass System is designed to make suturing obsolete (Photo courtesy of AMT Medical)

Pioneering Sutureless Coronary Bypass Technology to Eliminate Open-Chest Procedures

In patients with coronary artery disease, certain blood vessels may be narrowed or blocked, requiring a stent or a bypass (also known as diversion) to restore blood flow to the heart. Bypass surgeries... Read more